Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China
· Delayed Price · Currency is CNY 6.97
-0.05 (-0.71%)
Mar 11, 2026, 12:54 PM CST
SHE:002412 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,532 | 3,024 | 3,412 | 3,085 | 3,195 | 3,351 | Upgrade
|
| Market Cap Growth | 14.33% | -11.36% | 10.60% | -3.46% | -4.66% | -24.06% | Upgrade
|
| Enterprise Value | 3,102 | 2,733 | 3,276 | 2,981 | 3,247 | 3,370 | Upgrade
|
| Last Close Price | 7.02 | 6.01 | 6.78 | 5.86 | 6.07 | 6.37 | Upgrade
|
| PE Ratio | 20.53 | 13.73 | 16.64 | 18.40 | 23.70 | 31.57 | Upgrade
|
| Forward PE | - | 15.12 | 15.12 | 15.12 | 15.12 | 15.12 | Upgrade
|
| PS Ratio | 3.36 | 3.01 | 3.57 | 3.37 | 3.58 | 4.52 | Upgrade
|
| PB Ratio | 1.56 | 1.37 | 1.74 | 1.63 | 1.83 | 2.10 | Upgrade
|
| P/TBV Ratio | 1.59 | 1.40 | 1.78 | 1.67 | 1.94 | 2.31 | Upgrade
|
| P/FCF Ratio | 25.98 | 25.38 | 24.12 | 23.32 | - | 97.36 | Upgrade
|
| P/OCF Ratio | 23.00 | 23.12 | 21.20 | 21.45 | 15.03 | 20.50 | Upgrade
|
| EV/Sales Ratio | 2.95 | 2.72 | 3.43 | 3.26 | 3.64 | 4.55 | Upgrade
|
| EV/EBITDA Ratio | 10.69 | 9.88 | 14.62 | 16.13 | 18.31 | 24.75 | Upgrade
|
| EV/EBIT Ratio | 12.04 | 11.57 | 18.92 | 22.38 | 25.75 | 39.14 | Upgrade
|
| EV/FCF Ratio | 22.82 | 22.94 | 23.16 | 22.53 | - | 97.89 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.04 | 0.05 | 0.06 | 0.08 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.31 | 0.42 | 0.65 | 0.74 | 1.31 | Upgrade
|
| Debt / FCF Ratio | 0.41 | 0.71 | 0.67 | 0.91 | - | 5.17 | Upgrade
|
| Net Debt / Equity Ratio | -0.19 | -0.13 | -0.08 | -0.08 | 0.00 | 0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.48 | -1.04 | -0.71 | -0.87 | -0.04 | 0.55 | Upgrade
|
| Net Debt / FCF Ratio | -3.16 | -2.41 | -1.13 | -1.22 | 0.46 | 2.16 | Upgrade
|
| Asset Turnover | 0.42 | 0.41 | 0.41 | 0.42 | 0.45 | 0.39 | Upgrade
|
| Inventory Turnover | 1.15 | 1.10 | 1.10 | 1.53 | 2.74 | 2.68 | Upgrade
|
| Quick Ratio | 3.42 | 2.51 | 1.71 | 1.61 | 1.18 | 1.52 | Upgrade
|
| Current Ratio | 4.49 | 3.53 | 2.52 | 2.28 | 1.53 | 1.93 | Upgrade
|
| Return on Equity (ROE) | 7.89% | 10.57% | 10.63% | 9.22% | 8.08% | 6.79% | Upgrade
|
| Return on Assets (ROA) | 6.42% | 6.05% | 4.68% | 3.78% | 3.94% | 2.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.08% | 11.07% | 8.89% | 7.08% | 6.67% | 4.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.30% | 10.60% | 8.70% | 7.00% | 7.20% | 5.30% | Upgrade
|
| Earnings Yield | 4.87% | 7.28% | 6.01% | 5.43% | 4.22% | 3.17% | Upgrade
|
| FCF Yield | 3.85% | 3.94% | 4.15% | 4.29% | -0.53% | 1.03% | Upgrade
|
| Dividend Yield | - | - | - | 5.12% | - | - | Upgrade
|
| Payout Ratio | 1.13% | 1.16% | 75.44% | 2.43% | 4.88% | 42.75% | Upgrade
|
| Buyback Yield / Dilution | 0.04% | 0.01% | -0.01% | -0.01% | 0.03% | -0.02% | Upgrade
|
| Total Shareholder Return | 0.04% | 0.01% | -0.01% | 5.11% | 0.03% | -0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.